Cencora Inc (COR)
239.47
-0.29
(-0.12%)
USD |
NYSE |
Apr 26, 11:29
Cencora Enterprise Value: 49.88B for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 25, 2024 | 49.88B |
April 24, 2024 | 49.52B |
April 23, 2024 | 49.47B |
April 22, 2024 | 49.30B |
April 19, 2024 | 49.76B |
April 18, 2024 | 49.39B |
April 17, 2024 | 49.66B |
April 16, 2024 | 49.58B |
April 15, 2024 | 48.78B |
April 12, 2024 | 48.73B |
April 11, 2024 | 49.06B |
April 10, 2024 | 49.49B |
April 09, 2024 | 49.65B |
April 08, 2024 | 50.00B |
April 05, 2024 | 50.57B |
April 04, 2024 | 50.34B |
April 03, 2024 | 51.09B |
April 02, 2024 | 50.55B |
April 01, 2024 | 50.53B |
March 28, 2024 | 50.53B |
March 27, 2024 | 50.86B |
March 26, 2024 | 50.49B |
March 25, 2024 | 50.34B |
March 22, 2024 | 50.43B |
March 21, 2024 | 50.40B |
Date | Value |
---|---|
March 20, 2024 | 50.30B |
March 19, 2024 | 50.40B |
March 18, 2024 | 49.79B |
March 15, 2024 | 49.58B |
March 14, 2024 | 49.47B |
March 13, 2024 | 48.89B |
March 12, 2024 | 49.42B |
March 11, 2024 | 49.47B |
March 08, 2024 | 49.43B |
March 07, 2024 | 49.46B |
March 06, 2024 | 48.87B |
March 05, 2024 | 49.00B |
March 04, 2024 | 49.09B |
March 01, 2024 | 49.34B |
February 29, 2024 | 49.05B |
February 28, 2024 | 49.16B |
February 27, 2024 | 49.24B |
February 26, 2024 | 49.60B |
February 23, 2024 | 49.39B |
February 22, 2024 | 48.81B |
February 21, 2024 | 48.63B |
February 20, 2024 | 48.41B |
February 16, 2024 | 48.28B |
February 15, 2024 | 48.55B |
February 14, 2024 | 48.25B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
16.27B
Minimum
Mar 23 2020
51.09B
Maximum
Apr 03 2024
29.62B
Average
30.28B
Median
Nov 16 2021
Enterprise Value Benchmarks
Cardinal Health Inc | 25.38B |
McKesson Corp | 75.23B |
Weed Inc | 9.478M |
Pineapple Inc | 10.30M |
Zomedica Corp | 36.99M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 601.50M |
Revenue (Quarterly) | 72.25B |
Total Expenses (Quarterly) | 71.45B |
EPS Diluted (Quarterly) | 2.98 |
Gross Profit Margin (Quarterly) | 3.42% |
Profit Margin (Quarterly) | 0.83% |
Earnings Yield | 3.83% |
Operating Earnings Yield | 5.75% |
Normalized Earnings Yield | 4.288 |